Ono Pharmaceutical Acquires Multiple Research-Stage Oncology Programmes from KSQ Therapeutics
By Ashish Tripathi
Pharma Deals Review: Vol 2023 Issue 2 (Table of Contents)
Published: 4 Feb-2023
DOI: 10.3833/pdr.v2023.i2.2763 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In a bid to bolster its oncology pipeline, Ono Pharmaceutical has agreed to acquire multiple research-stage oncology programmes from KSQ Therapeutics...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS